Earnings Call · Q1 FY2024·2024-05-14

Q1 24EPS -8.70%·Rev n/aQ4 23EPS -7.69%·Rev n/aQ3 23EPS +7.69%·Rev n/aQ2 23EPS +17.65%·Rev n/a⚠ consensus missing

Acumen Pharmaceuticals, Inc. ABOS

Alex Braun — Vice President

Daniel O’Connell

Matt Zuga — Chief Financial Officer (CFO) and Chief Business Officer

+9.8%1d on move date+9.4% vs SPY3d+11.0%5d+14.3%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ABOS calls or request research access.

More ABOS calls Browse calls Request research access